A dose planning study for cardiac and lung dose sparing techniques in left breast cancer radiotherapy: Can free breathing helical tomotherapy be considered as an alternative for deep inspiration breath hold?
- PMID: 36798947
- PMCID: PMC9926227
- DOI: 10.1016/j.tipsro.2023.100201
A dose planning study for cardiac and lung dose sparing techniques in left breast cancer radiotherapy: Can free breathing helical tomotherapy be considered as an alternative for deep inspiration breath hold?
Abstract
Purpose: To investigate the possibility to be able to offer left sided breast cancer patients, not suitable for DIBH, an organ at risk saving treatment.
Materials and methods: Twenty patients receiving radiotherapy for left breast cancer in DIBH were enrolled in the study. Planning CT scans were acquired in the same supine treatment position in FB and DIBH. 3DCRT_DIBH plans were designed and optimized using two parallel opposed tangent beams (with some additional segments) for the breast and chest wall and anterior-posterior fields for regional lymph nodes irradiation. Additionally, FB helical tomotherapy plans were optimized to minimize heart and lung dose. All forty plans were optimized with at least 95% of the total CTV covered by the 95% of prescribed dose of 50 Gy in 25 fractions.
Results: HT_FB plans showed significantly better dose homogeneity and conformity compared to the 3DCRT_DIBH specially for regional nodal irradiation. The heart mean dose was almost comparable in 3DCRT_DIBH and HT_FB while the volume (%) of the heart receiving 25 Gy had a statistically significant reduction from 7.90 ± 3.33 in 3DCRT_DIBH to 0.88 ± 0.66 in HT_FB. HT_FB was also more effective in left descending artery (LAD) mean dose reduction about 100% from 30.83 ± 9.2 Gy to 9.7 ± 3.1. The ipsilateral lung volume receiving 20 Gy has a further reduction of 43 % in HT_FB compared with 3DCRT_DIBH. For low dose comparison, 3DCRT_DIBH was superior for contralateral organ sparing compared to the HT_FB due to the limited angle for dose delivery.
Conclusion: For patients who cannot be a candidate for DIBH for any reason, HT in free breathing may be a good alternative and provides heart and ipsilateral lung dose sparing, however with the cost of increased dose to contralateral breast and lung.
Keywords: Deep inspiration breath-hold; Helical Tomotherapy; Left breast radiotherapy; Toxicity management.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Evaluation of helical tomotherapy as an alternative for left-sided breast cancer patients not compliant with deep inspiration breath hold.Tech Innov Patient Support Radiat Oncol. 2024 Aug 6;31:100268. doi: 10.1016/j.tipsro.2024.100268. eCollection 2024 Sep. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 39247163 Free PMC article.
-
Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer.Cureus. 2020 Mar 12;12(3):e7247. doi: 10.7759/cureus.7247. Cureus. 2020. PMID: 32292662 Free PMC article.
-
Is the Deep Inspiration Breath-Hold Technique Superior to the Free Breathing Technique in Cardiac and Lung Sparing while Treating both Left-Sided Post-Mastectomy Chest Wall and Supraclavicular Regions?Case Rep Oncol. 2017 Jan 16;10(1):37-51. doi: 10.1159/000453607. eCollection 2017 Jan-Apr. Case Rep Oncol. 2017. PMID: 28203163 Free PMC article.
-
A Systematic Review of Deep Inspiration Breath Hold and Free Breathing in Proton Beam Therapy Plans for Breast Cancer Radiotherapy.Clin Oncol (R Coll Radiol). 2025 Apr;40:103782. doi: 10.1016/j.clon.2025.103782. Epub 2025 Feb 1. Clin Oncol (R Coll Radiol). 2025. PMID: 39999640
-
Heart Sparing Radiotherapy Techniques in Breast Cancer: A Focus on Deep Inspiration Breath Hold.Breast Cancer (Dove Med Press). 2022 Jul 20;14:175-186. doi: 10.2147/BCTT.S282799. eCollection 2022. Breast Cancer (Dove Med Press). 2022. PMID: 35899145 Free PMC article. Review.
Cited by
-
Hybrid VMAT-3DCRT as breast cancer treatment improvement tool.Sci Rep. 2024 Jan 3;13(1):23110. doi: 10.1038/s41598-023-50538-x. Sci Rep. 2024. PMID: 38172237 Free PMC article.
-
Evaluation of helical tomotherapy as an alternative for left-sided breast cancer patients not compliant with deep inspiration breath hold.Tech Innov Patient Support Radiat Oncol. 2024 Aug 6;31:100268. doi: 10.1016/j.tipsro.2024.100268. eCollection 2024 Sep. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 39247163 Free PMC article.
References
-
- Whelan T.J., Pignol J.P., Levine M.N., Julian J.A., MacKenzie R., Parpia S., et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513–520. - PubMed
-
- Bartelink H., Horiot J.C., Poortmans P.M., Struikmans H., Van den Bogaert W., Fourquet A., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881–10882 trial. J Clin Oncol. 2007;25(22):3259–3265. - PubMed
-
- Emdin S.O., Granstrand B., Ringberg A., Sandelin K., Arnesson L.G., Nordgren H., et al. Swedish Breast Cancer Group). SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006;45(5):536–543. - PubMed
-
- Bijker N., Meijnen P., Peterse J.L., Bogaerts J., Van Hoorebeeck I., Julien J.P., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853—a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381–3387. - PubMed
LinkOut - more resources
Full Text Sources